120 related articles for article (PubMed ID: 1260747)
1. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
Marks TA; Venditti JM
Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
[TBL] [Abstract][Full Text] [Related]
2. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
Israel M; Modest EJ; Frei E
Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
[TBL] [Abstract][Full Text] [Related]
3. DNA breaks in P288 tumor cells in mice after treatment with daunorubicin and adriamycin.
Schwartz HS
Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):51-64. PubMed ID: 1124321
[TBL] [Abstract][Full Text] [Related]
4. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
Mantovani A; Polentarutti N; Luini W; Peri G; Spreafico F
J Natl Cancer Inst; 1979 Jul; 63(1):61-6. PubMed ID: 286835
[No Abstract] [Full Text] [Related]
5. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
6. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
7. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of methylene blue in vivo].
Lai BT
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):98-100. PubMed ID: 2806052
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
Flora KP; van't Riet B; Wampler GL
Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
Avery TL; Roberts D
Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
[TBL] [Abstract][Full Text] [Related]
14. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
Trouet A; Sokal G
Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556
[TBL] [Abstract][Full Text] [Related]
15. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
Pacciarini MA; Barbieri B; Colombo T; Broggini M; Garattini S; Donelli MG
Cancer Treat Rep; 1978 May; 62(5):791-800. PubMed ID: 657163
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
[TBL] [Abstract][Full Text] [Related]
17. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
[TBL] [Abstract][Full Text] [Related]
18. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).
Woodman RJ; Cysyk RL; Kline I; Gang M; Venditti JM
Cancer Chemother Rep; 1975; 59(4):689-95. PubMed ID: 1175163
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and preliminary drug disposition studies on chartreusin (NSC 5159).
McGovren JP; Neil GL; Crampton SL; Robinson MI; Douros JD
Cancer Res; 1977 Jun; 37(6):1666-72. PubMed ID: 870180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
